TSPAN7
protein-codingtetraspanin 7, the group of Tetraspanins|CD molecules
Gene summary
The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein and may have a role in the control of neurite outgrowth. It is known to complex with integrins. This gene is associated with X-linked cognitive disability and neuropsychiatric diseases such as Huntington's chorea, fragile X syndrome and myotonic dystrophy. [provided by RefSeq, Jul 2008]
- MXS1
- TM4SF2
- MRX58
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~127.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010266
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: ClinGen
TSPAN7 was initially reported in relation to X-linked intellectual disability in 2000 (PMID: 10655063). A female with mild intellectual disability was found to carry a balanced translocation [46,X,t(X;2)(p11.4;p21.3)] with a breakpoint within TSPAN7 that disrupted its expression. Though this case was not scored, it ultimately led to further investigation of this gene as a potential cause for X-linked intellectual disability (PMID: 10655063). One family with multiple affected males was found to have a nonsense variant. Another family was found to have a missense variant (NM_004615.3:c.515C>A, p.Pro172His); this variant was also reported in other manuscripts as being observed in individuals with intellectual disability or autism spectrum disorder (PMIDs: 14735593, 20479760). This variant was subsequently found to be observed at frequencies too high in the general population to be consistent with disease (205 total alleles across various populations in gnomAD v.2.1.1, including 66 hemizygotes), and was therefore not scored as evidence to support this gene disease relationship. Since the initial report, only two other frameshift variants have been reported: one in four affected males in a family with X-linked intellectual disability (PMID: 12070254), and the other in a male with intellectual disability (PMID: 26350204). Other articles reported individuals with intellectual disability or autism spectrum disorder with a partial duplication of TSPAN7 spanning exons 2-8 (PMID: 22511893, 19339915, 24768552, 25661985). This recurrent duplication is of uncertain significance and was therefore not scored. There is experimental evidence to support this gene-disease relationship, including functional alteration in hippocampal neurons (PMID:22445342) and a mouse model (PMID:28968657). In summary, there is moderate evidence supporting a relationship between TSPAN7 and X-linked intellectual disability. This curation was approved by the ClinGen ID/Autism GCEP on December 2, 2020 (SOP v8).
Inheritance Pattern: XL
Disease ID:MONDO:0010266
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010266
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TSPAN7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004615.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 5 | 2 | 18 | ||
| missense | 53 | 3 | 56 | |||
| nonsense | 2 | 7 | 9 | |||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 1 | 15 | 16 | |||
| Total | 4 | 1 | 87 | 8 | 2 | 102 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004606.2 | 7 | MANE Select | |
| Ensembl | ENSP00000367743.2 | 7 | MANE Select | |
| Ensembl | ENSP00000286824.6 | 8 | Standard | |
| Ensembl | ENSP00000286824.6 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transcriptional misregulation in cancer - Homo sapiens (human)
- Neuronal System
- Cell surface interactions at the vascular wall
- Hemostasis
- Trafficking of GluR2-containing AMPA receptors
Biological Process
- cell surface receptor signaling pathway
- viral process
Cellular Component
- integral component of plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378482
- Coding exons
- 7
- Length
- 127547
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.91 | 48 | 102 | 0.470 | 0.00000796 | 1622 |
| Missense (PolyPhen) | 2 | 23.027 | 0.086853 | 411 | ||
| Synonymous | -0.180 | 43 | 41.5 | 1.04 | 0.00000343 | 496 |
| Loss of Function | 2.45 | 1 | 8.86 | 0.113 | 6.45e-7 | 145 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in cell proliferation and cell motility.;
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- RVIS EVS
- -0.08
- RVIS percentile EVS
- 47.79
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.233
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Low | Low | Low |
| Primary Immunodeficiency | Low | Low | Low |
| Cancer | Low | Low | Low |